Wednesday, April 22, 2015

Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.

No substantial increase was found in the prevalence of overall cardiac birth defects among infants exposed to SSRIs (e.g. fluoxetine, sertraline)or venlafaxine in utero.  (BMJ. 2015 Apr 17;350:h1798.)
Read More